ArticleInternational journal of clinical and experimental medicine2015

Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.

You-Cheng Lin et al.PubMed ↗Full text ↗

No numbers read from the abstract.